Smith, Salley & Associates Abbott Laboratories Transaction History

Smith, Salley & Associates

$1.48 Billion
Q3 2024

A detailed history of Smith, Salley & Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Smith, Salley & Associates holds 170,650 shares of ABT stock, worth $19.2 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

170,650

Previous 166,397 2.56%

Holding current value

$19.2 Million

Previous $17.3 Million 12.52%

% of portfolio

1.32%

Previous 1.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $425,597 - $502,406	4,253 Added 2.56%	170,650 $19.5 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $1.84 Million - $2.06 Million	18,283 Added 12.34%	166,397 $17.3 Million
Q1 2024 May 02, 2024	SELL	$109.52 - $120.96 $4.62 Million - $5.11 Million	-42,216 Reduced 22.18%	148,114 $16.8 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $547,092 - $669,686	6,066 Added 3.29%	190,330 $20.9 Million
Q3 2023 Oct 27, 2023	BUY	$95.53 - $114.62 $557,513 - $668,922	5,836 Added 3.27%	184,264 $17.8 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $3,930 - $4,379	-39 Reduced 0.02%	178,428 $19.5 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $417,369 - $491,269	4,309 Added 2.47%	178,467 $18.1 Million
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $29,278 - $34,348	-308 Reduced 0.18%	174,158 $19.1 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $66,570 - $77,076	688 Added 0.4%	174,466 $16.9 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $648,552 - $783,892	6,354 Added 3.8%	173,778 $18.9 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $254,720 - $310,615	2,234 Added 1.35%	167,424 $19.8 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $10,859 - $13,297	94 Added 0.06%	165,190 $23.2 Million
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $343,213 - $379,694	2,942 Added 1.81%	165,096 $19.5 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $584,912 - $688,526	5,529 Added 3.53%	162,154 $18.8 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $774,940 - $912,997	7,120 Added 4.76%	156,625 $18.8 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $859,530 - $936,642	8,186 Added 5.79%	149,505 $16.4 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $80,001 - $97,156	873 Added 0.62%	141,319 $15.4 Million
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $455,361 - $582,806	5,947 Added 4.42%	140,446 $12.8 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $201,024 - $293,952	3,200 Added 2.44%	134,499 $10.6 Million
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $70,659 - $78,660	900 Added 0.69%	131,299 $11.4 Million
Q3 2019 Oct 30, 2019	BUY	$81.84 - $88.74 $365,906 - $396,756	4,471 Added 3.55%	130,399 $10.9 Million
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $1.81 Million - $2.11 Million	-24,775 Reduced 16.44%	125,928 $10.6 Million
Q1 2019 May 03, 2019	BUY	$66.22 - $80.06 $381,029 - $460,665	5,754 Added 3.97%	150,703 $12 Million
Q4 2018 Feb 05, 2019	BUY	$65.56 - $74.27 $244,735 - $277,249	3,733 Added 2.64%	144,949 $10.5 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $243,908 - $294,246	4,011 Added 2.92%	141,216 $10.4 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $153,308 - $169,207	2,663 Added 1.98%	137,205 $8.37 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $241,567 - $273,120	4,293 Added 3.3%	134,542 $8.06 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $160,986 - $172,352	2,999 Added 2.36%	130,249 $7.43 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $6.12 Million - $6.83 Million	127,250	127,250 $6.79 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Account

Smith, Salley & Associates Abbott Laboratories Transaction History